Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218).
about
Deubiquitinases in cancer.DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells.Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.Inhibition of USP10 induces degradation of oncogenic FLT3.Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
P2860
Q35955141-3AB09A70-90B3-45AA-90FC-ADCF942C7651Q38911123-33602C93-1A33-4D58-8A4E-62E68B5D4D58Q39381468-84300ECA-9186-4581-A39B-542FBF4176CCQ40495744-E1DF8674-B870-4114-BD2D-00EDEDAB5689Q47619828-722EC6F2-BE01-4515-9059-D6274601B15EQ47716589-C8D824CD-9932-4C4C-89BB-DC3FD1DB6778Q48188572-04F7CF98-BFAD-448F-BBD6-2563CA18A06BQ58749340-1ACA8D31-5B49-49C3-91C3-B1CB0C26638E
P2860
Selective and reversible inhibitors of ubiquitin-specific protease 7: a patent evaluation (WO2013030218).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Selective and reversible inhib ...... ent evaluation (WO2013030218).
@en
type
label
Selective and reversible inhib ...... ent evaluation (WO2013030218).
@en
prefLabel
Selective and reversible inhib ...... ent evaluation (WO2013030218).
@en
P2860
P1476
Selective and reversible inhib ...... ent evaluation (WO2013030218).
@en
P2860
P304
P356
10.1517/13543776.2014.882320
P407
P577
2014-01-24T00:00:00Z